They were placed on your computer when you launched this website. This is an incredibly scalable solution that is very much needed to screen as many people as possible in the shortest time," stated Thomas B. Pickens III, Chairman and Chief Executive Officer of Astrotech Corporation.In addition, the Company will be launching a new subsidiary company, BreathTech Corporation, that will hold the exclusive license to use the 1Astrotech (NASDAQ: ASTC) is a science and technology development and commercialization company that launches, manages, and builds scalable companies based on innovative technology in order to maximize shareholder value. The Austin-based research and … It has also been certified by the European Civil Aviation Conference (ECAC) and is now deployed in air cargo facilities throughout the European Union. The BreathTest-1000™ is not expected to be as accurate as laboratory DNA testing but could be an excellent quick screening device for field applications.The development of the BreathTest-1000 follows the Company’s announcement on June 15"With the Coronavirus pandemic impacting millions of families around the globe, we are now very focused on the development of a rugged, inexpensive, quick, and easy to use testing platform that can be deployed to thousands of point-of-care locations worldwide, if approved. It intends to use the net proceeds for continuing operating expenses and working capital.The push for drive-up testing with fast results has been gaining momentum, even as issues with testing overall remain. This process requires many days to ship, process, and receive the results, exacerbating the problem while people spread the disease. For information, please visit Eric Stober, Chief Financial Officer, Astrotech Corporation, (512) 485-9530Ian Royce dead: Tributes pour in for Britain's Got Talent star who died after battle with pneumoniaJvion Lauded by Frost & Sullivan for Improving Patient Outcomes Using Its Clinical-AI CORE™ Intelligence PlatformIndonesia stages coffin parade as reminder of virus threatIndia leads global rise in new weekly COVID-19 cases, while deaths down: WHOSanofi says Kevzara drug fails as possible COVID-19 treatment‘Ghosting’ is not just for lovers. Of note, testing would take less than a minute and require minimal training.In today’s testing situation, samples are collected off-site and sent to centrally located labs. Astrotech believes that the technology can be designed as an instrument that can be deployed on the field as drive-up testing facilities to quickly, under one minute, and easily test for the volatile organic compound metabolites in the breath of coronavirus and pneumonia infected patients..
The entire process, which includes shipping, processing and taking in the results, requires several days. Astrotech Corp., of Austin, Texas, has a broad range, having developed mass spectrometers in agriculture and manufacturing and selling chemical analyzers for use in the airport security and other applications. It acknowledged that Breathtest-1000 probably will not be as accurate as laboratory DNA testing, but it will help in terms of being a quick screening device.To help achieve this goal, the company is launching a new subsidiary company, Breathtech Corp., that will hold the exclusive license to use the 1st Detect Technology for breath analysis.
With the BreathTest-1000™, testing is performed at the point-of-care and the screening results are near-instant.
You can change your cookie settings through your browser.
(RTTNews) - Shares of Astrotech Corp. (ASTC) jumped over 260% on Wednesday morning after medical equipment maker announced that it is developing a instrument to screen COVID-19. AgLAB develops, manufactures, and sells chemical analyzers for use in the agriculture market.
These job applicants say 'cruel' and 'selfish' employers do it too. 1st Detect develops, manufactures, and sells explosives trace detectors for use in the security and detection market. Astrotech is headquartered in Austin, Texas. 'The reality is our deal makes the most sense' : Triller Executive Chairman on the company's bid for TikTokFederal Reserve: We got it ‘wrong’ on post-crisis rate hikesLoan company sued thousands of low-income Latinos during pandemic: reportHow Gamelancer is helping gamers earn revenue as freelancers for hireWorkers will see smaller paychecks next year under Trump's payroll tax deferralWalmart unveils 'ultimate life hack,' a $98 membership with access to gas, groceries and free deliveryThe Trump payroll tax break you won’t see on your paycheckOkta CEO is crushing burpees — and quarterly earningsMARKETS: Nasdaq, S&P 500 surge to record closing highs — YF Premium is bearish on Chegg (CHGG) Astrotech Corp. is working to create a device that could quickly test for the COVID-19 virus at drive-thru locations. At this time, the 2020 AstroTech Summer School at UC Berkeley is scheduled to take place as planned. Astrotech Corporation [NASDAQ: ASTC] today announced that the BreathTest-1000™ is under development to screen for volatile organic compound (VOC) metabolites found in … The company went on to sell ASO and ultimately decided to focus on being a business accelerator.Now it has stepped to the plate in terms of fighting COVID-19 and the pneumonia that result with the development of the Breathtest-1000 to screen for volatile organic compound (VOC) metabolites, which are found in a person’s breath and could indicate an infection.Astrotech’s mass spectrometry technology is designed for assessing air quality monitoring and trace detection of chemical warfare agents, explosives and narcotics.
A possible solution he highlighted is having top logistics companies, such as Amazon and Fedex, create a command center and distribute kits where they are needed and ship samples to where there is excess capacity.Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.Copyright ©2020. It subsequently focused on its satellite processing business, Astrotech Space Operations (ASO), as well as 1st Detect, its mass spectrometer instrumentation business, and Astrogenetix, its microgravity vaccine development company.